NO20045233L - Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse - Google Patents
Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelseInfo
- Publication number
- NO20045233L NO20045233L NO20045233A NO20045233A NO20045233L NO 20045233 L NO20045233 L NO 20045233L NO 20045233 A NO20045233 A NO 20045233A NO 20045233 A NO20045233 A NO 20045233A NO 20045233 L NO20045233 L NO 20045233L
- Authority
- NO
- Norway
- Prior art keywords
- forms
- ondansetron
- processes
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Ondansetron krystallinske former A og B er anvendbare i behandlingen av kvalme og brekningsfornemmelse. Form B har et unikt høyt smeltepunkt på omtrent 244 ºC, og begge formene er stabile mot termisk indusert polymorf overgang fra 30 ºC opp til deres smeltepunkter.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37639502P | 2002-04-30 | 2002-04-30 | |
PCT/US2003/013220 WO2003093260A1 (en) | 2002-04-30 | 2003-04-29 | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20045233L true NO20045233L (no) | 2005-01-28 |
Family
ID=29401340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20045233A NO20045233L (no) | 2002-04-30 | 2004-11-29 | Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse |
Country Status (15)
Country | Link |
---|---|
US (1) | US20040019093A1 (no) |
EP (1) | EP1465887A1 (no) |
JP (1) | JP2005529908A (no) |
KR (1) | KR20040104677A (no) |
CN (1) | CN1665803A (no) |
AU (1) | AU2003223763A1 (no) |
CA (1) | CA2483532A1 (no) |
DE (1) | DE20320528U1 (no) |
HR (1) | HRP20041136A2 (no) |
IL (1) | IL164905A0 (no) |
MX (1) | MXPA04010845A (no) |
NO (1) | NO20045233L (no) |
PL (1) | PL373192A1 (no) |
WO (1) | WO2003093260A1 (no) |
ZA (1) | ZA200408935B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2426026A1 (en) * | 2000-10-30 | 2002-05-10 | Judith Aronhime | Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
US7098345B2 (en) * | 2002-04-29 | 2006-08-29 | TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one |
FI6164U1 (fi) * | 2003-01-09 | 2004-03-15 | Synthon Bv | Ondansetronmuotoja |
ES2238001B1 (es) * | 2004-01-21 | 2006-11-01 | Vita Cientifica, S.L. | Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos. |
US7288660B2 (en) * | 2004-05-07 | 2007-10-30 | Taro Pharmaceutical Industries Limited | Process for preparing ondansetron hydrochloride dihydrate having a defined particle size |
TW200800954A (en) * | 2006-03-16 | 2008-01-01 | Astrazeneca Ab | Novel crystal modifications |
MX2009003372A (es) | 2006-10-02 | 2009-09-24 | Labtec Gmbh | Formas de dosificacion de pelicula no mucoadhesiva. |
RU2560693C2 (ru) | 2010-03-23 | 2015-08-20 | Апр Эпплайд Фарма Рисерч, С.А. | Быстро растворяющиеся системы, освобождающие лекарственные препараты |
EP2377526A1 (en) | 2010-03-23 | 2011-10-19 | BioAlliance Pharma | Fast dissolving drug delivery systems |
TW201946625A (zh) | 2013-11-15 | 2019-12-16 | 美商阿克比治療有限公司 | {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8518745D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
HU196598B (en) * | 1986-04-25 | 1988-12-28 | Richter Gedeon Vegyeszet | Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds |
GB8630071D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
US5344658A (en) * | 1989-06-28 | 1994-09-06 | Glaxo Group Limited | Process and composition using ondansetron |
CA2112487C (en) * | 1991-06-26 | 2003-04-15 | James W. Young | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
CA2106642C (en) * | 1992-10-14 | 2005-08-16 | Peter Bod | Carbazolone derivatives and process for preparing the same |
GB2291005B (en) * | 1994-07-08 | 1998-05-20 | Milwaukee Electric Tool Corp | Bevel angle adjustment mechanism for a compound mitre saw |
GB9423588D0 (en) * | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
GB9423511D0 (en) * | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
JP3533519B2 (ja) * | 2000-03-09 | 2004-05-31 | 株式会社アドバンスト・ディスプレイ | Tft基板、フィルムキャリアおよび液晶表示素子の製法 |
US20020115707A1 (en) * | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
US7098345B2 (en) * | 2002-04-29 | 2006-08-29 | TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one |
-
2003
- 2003-04-29 PL PL03373192A patent/PL373192A1/xx not_active Application Discontinuation
- 2003-04-29 CA CA002483532A patent/CA2483532A1/en not_active Abandoned
- 2003-04-29 AU AU2003223763A patent/AU2003223763A1/en not_active Abandoned
- 2003-04-29 EP EP03719967A patent/EP1465887A1/en not_active Withdrawn
- 2003-04-29 WO PCT/US2003/013220 patent/WO2003093260A1/en active Application Filing
- 2003-04-29 DE DE20320528U patent/DE20320528U1/de not_active Expired - Lifetime
- 2003-04-29 MX MXPA04010845A patent/MXPA04010845A/es unknown
- 2003-04-29 KR KR10-2004-7017467A patent/KR20040104677A/ko active IP Right Grant
- 2003-04-29 CN CN038155818A patent/CN1665803A/zh active Pending
- 2003-04-29 JP JP2004501399A patent/JP2005529908A/ja active Pending
- 2003-04-29 US US10/425,210 patent/US20040019093A1/en not_active Abandoned
-
2004
- 2004-10-28 IL IL16490504A patent/IL164905A0/xx unknown
- 2004-11-04 ZA ZA200408935A patent/ZA200408935B/en unknown
- 2004-11-26 HR HR20041136A patent/HRP20041136A2/hr not_active Application Discontinuation
- 2004-11-29 NO NO20045233A patent/NO20045233L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20040019093A1 (en) | 2004-01-29 |
PL373192A1 (en) | 2005-08-22 |
HRP20041136A2 (en) | 2005-04-30 |
EP1465887A1 (en) | 2004-10-13 |
WO2003093260A1 (en) | 2003-11-13 |
ZA200408935B (en) | 2006-07-26 |
CN1665803A (zh) | 2005-09-07 |
CA2483532A1 (en) | 2003-11-13 |
IL164905A0 (en) | 2005-12-18 |
KR20040104677A (ko) | 2004-12-10 |
AU2003223763A1 (en) | 2003-11-17 |
MXPA04010845A (es) | 2005-01-25 |
DE20320528U1 (de) | 2004-09-16 |
JP2005529908A (ja) | 2005-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20074558L (no) | Krystallisasjon og rensing av glykopyrroniumbromid | |
NO20045233L (no) | Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse | |
NO20044221L (no) | Nye forbindelser | |
MEP21908A (en) | Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same | |
NO20055454L (no) | Smeltedigel til en innretning for a produsere en blokk av krystallinsk materiale og en fremgangsmate for a produsere denne | |
MX2009007141A (es) | Acidos 1-(3-piridinil)pirazol-4-il-aceticos sustituidos, procedimiento para su preparacion y su utilizacion como agentes herbicidas y reguladores del crecimiento de las plantas. | |
MX2009004351A (es) | Anticuerpos anti-htnfalfa cristalinos. | |
PE20050078A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
MXPA05008705A (es) | Derivados de piridina como compuestos fungicidas. | |
NO20055688L (no) | Organiske forbindelser | |
CO5690637A2 (es) | Tiazol-(bi) cicloalquil-carboxanilidas | |
DK1831239T5 (da) | Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde | |
PL1670778T3 (pl) | Przegrupowane pentanole, sposób ich wytwarzania i ich zastosowanie jako środków hamujących zapalenia | |
NO20064606L (no) | Fremgangsmate for a redusere dioksininnholdet av blekejord | |
DK2219998T3 (da) | Krystalliseret faststof IM-18 og fremgangsmåde til fremstilling heraf | |
ATE350123T1 (de) | Niedrigtemperaturprozess zum extrahieren der hauptkomponenten aus pflanzen | |
ATE527248T1 (de) | Polymorphe von enantioreinem erdostein | |
DK1873152T3 (da) | Hidtil ukendt fremgangsmåde til oprensning af Moxonidin | |
ATE297893T1 (de) | Verfahren zur herstellung von pyrrolidonen | |
ATE502045T1 (de) | Verfahren zur herstellung von perindoprilerbumin | |
TW200628465A (en) | Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds | |
NO20092214L (no) | Krystallinske former av aryl-substituerte pyrazol-amid forbindelser | |
DK0961770T3 (da) | Fremgangsmåder til fremstilling af 3-cyanopyridin ud fra 2-methyl-1,5-pentandiamin | |
MX2007006843A (es) | Proceso para hacer una composicion de barra teniendo poco o ninguna eflorescencia. | |
DK1513838T3 (da) | Teknisk fremgangsmåde til fremstilling af tropenol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |